{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T13:38:01Z","timestamp":1782999481649,"version":"3.54.5"},"reference-count":67,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Myasthenia gravis (MG) is the most common neuromuscular junction disorder. We evaluated the MG incidence rate in the province of Ferrara, Northern Italy, over two time frames (2008\u20132018 and 2019\u20132022, i.e., the COVID-19 pandemic) and considered early-onset (EOMG), late-onset (LOMG), and thymoma- and non-thymoma-associated MG. Moreover, in the second period, we assessed its possible relationship with SARS-CoV-2 infection or COVID-19 vaccination. We used a complete enumeration approach to estimate the MG incidence and its temporal trend. For the period of 2008\u201318, 106 new cases were identified (mean incidence rate 2.7\/100,000 people). The highest rates were observed for the over-70 age group and in rural areas, with 17% of thymoma-associated MG. During the COVID-19 period, 29 new cases were identified (average incidence rate 2.1\/100,000 people), showing a marked (though not statistically significant) decrease in the mean annual incidence compared to the previous period. Again, the highest rate was observed for the over-70 age group. The first period was in line with our previous observations for the period between 1985 and 2007, highlighting a rising incidence of LOMG and a marked decrease in EOMG. During the COVID-19 period, incidence rates were lower in the first years whereas, when the pandemic ended, the previous trend was confirmed.<\/jats:p>","DOI":"10.3390\/jcm13010236","type":"journal-article","created":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T06:00:21Z","timestamp":1704002421000},"page":"236","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Incidence of Myasthenia Gravis in the Province of Ferrara, Italy, in the Period of 2008\u20132022: An Update on a 40-Year Observation and the Influence of the COVID-19 Pandemic"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1555-6418","authenticated-orcid":false,"given":"Annibale","family":"Antonioni","sequence":"first","affiliation":[{"name":"Unit of Neurology, Department of Neurosciences and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy"},{"name":"Doctoral Program in Translational Neurosciences and Neurotechnologies, Department of Neurosciences and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela Maria","family":"Raho","sequence":"additional","affiliation":[{"name":"Unit of Neurology, Department of Neurosciences and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Carlucci","sequence":"additional","affiliation":[{"name":"Unit of Neurology, Department of Neurosciences and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Sette","sequence":"additional","affiliation":[{"name":"Unit of Neurology, Interdistrict Health Care Department of Neurosciences, S. Anna Ferrara University Hospital, 44124 Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"De Gennaro","sequence":"additional","affiliation":[{"name":"Unit of Neurology, Interdistrict Health Care Department of Neurosciences, S. Anna Ferrara University Hospital, 44124 Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4313-5349","authenticated-orcid":false,"given":"Jay Guido","family":"Capone","sequence":"additional","affiliation":[{"name":"Unit of Neurology, Interdistrict Health Care Department of Neurosciences, S. Anna Ferrara University Hospital, 44124 Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Govoni","sequence":"additional","affiliation":[{"name":"Unit of Neurology, Department of Neurosciences and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Casetta","sequence":"additional","affiliation":[{"name":"Unit of Neurology, Department of Neurosciences and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Pugliatti","sequence":"additional","affiliation":[{"name":"Unit of Neurology, Department of Neurosciences and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Granieri","sequence":"additional","affiliation":[{"name":"Unit of Neurology, Department of Neurosciences and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/B978-0-323-98818-6.00010-8","article-title":"Myasthenia gravis and congenital myasthenic syndromes","volume":"195","author":"Gilhus","year":"2023","journal-title":"Handb. Clin. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: Emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia Gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Dresser, L., Wlodarski, R., Rezania, K., and Soliven, B. (2021). Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations. J. Clin. Med., 10.","DOI":"10.3390\/jcm10112235"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.25122\/jml-2020-0145","article-title":"The epidemiology of myasthenia gravis","volume":"14","author":"Bubuioc","year":"2021","journal-title":"J. Med. Life"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000279334","article-title":"The incidence of myasthenia gravis: A systematic literature review","volume":"34","author":"McGrogan","year":"2010","journal-title":"Neuroepidemiology"},{"key":"ref_7","unstructured":"Rosati, G., and Granieri, E. (1990). Manuale di Neuroepidemiologia Clinica, La Nuova Italia Scientifica."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Carr, A.S., Cardwell, C.R., McCarron, P.O., and McConville, J. (2010). A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol., 10.","DOI":"10.1186\/1471-2377-10-46"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000500268","article-title":"A Prospective Study of the Incidence of Myasthenia Gravis in the East Midlands of England","volume":"53","author":"Maddison","year":"2019","journal-title":"Neuroepidemiology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ajo.2019.04.017","article-title":"Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study","volume":"205","author":"Hendricks","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nmd.2015.10.009","article-title":"Epidemiology of myasthenia gravis in Ontario, Canada","volume":"26","author":"Breiner","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/jnnp.2008.152637","article-title":"Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan","volume":"80","author":"Matsui","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/01.wnl.0000176067.32186.a3","article-title":"Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis","volume":"65","author":"Somnier","year":"2005","journal-title":"Neurology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1212\/01.WNL.0000050461.05432.C5","article-title":"Myasthenia gravis: A higher than expected incidence in the elderly","volume":"60","author":"Bonfill","year":"2003","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1196\/annals.1405.040","article-title":"Myasthenia gravis in the elderly: Is it different?","volume":"1132","author":"Aarli","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000487886","article-title":"Epidemiology of Myasthenia Gravis in Slovakia in the Years 1977\u20132015","volume":"50","author":"Martinka","year":"2018","journal-title":"Neuroepidemiology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3349\/ymj.2016.57.2.419","article-title":"The Epidemiology of Myasthenia Gravis in Korea","volume":"57","author":"Lee","year":"2016","journal-title":"Yonsei Med. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2011.03.004","article-title":"Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey","volume":"305","author":"Murai","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"100063","DOI":"10.1016\/j.lanwpc.2020.100063","article-title":"Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study","volume":"5","author":"Chen","year":"2020","journal-title":"Lancet Reg. Health West. Pac."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/JND-140045","article-title":"The Epidemiology of Neuromuscular Disorders: A Comprehensive Overview of the Literature","volume":"2","author":"Deenen","year":"2015","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e16367","DOI":"10.1016\/j.heliyon.2023.e16367","article-title":"Real world study on prevalence, treatment and economic burden of myasthenia gravis in Italy","volume":"9","author":"Antonini","year":"2023","journal-title":"Heliyon"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00415-010-5651-z","article-title":"Myasthenia gravis: A changing pattern of incidence","volume":"257","author":"Casetta","year":"2010","journal-title":"J. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000080093","article-title":"Incidence of myasthenia gravis in the province of Ferrara: A community-based study","volume":"23","author":"Casetta","year":"2004","journal-title":"Neuroepidemiology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5578284","DOI":"10.1155\/2022\/5578284","article-title":"COVID-19 Impact on Public Health, Environment, Human Psychology, Global Socioeconomy, and Education","volume":"2022","author":"Miyah","year":"2022","journal-title":"Sci. World J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1631\/jzus.B2000083","article-title":"An overview of COVID-19","volume":"21","author":"Shi","year":"2020","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"101462","DOI":"10.1016\/j.eclinm.2022.101462","article-title":"Impact of first UK COVID-19 lockdown on hospital admissions: Interrupted time series study of 32 million people","volume":"49","author":"Shah","year":"2022","journal-title":"eClinicalMedicine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/WCO.0000000000000879","article-title":"Stroke epidemiology and COVID-19 pandemic","volume":"34","author":"Logroscino","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000529583","article-title":"Incidence, Prevalence, Hospitalization Rates, and Treatment Patterns in Myasthenia Gravis: A 10-Year Real-World Data Analysis of German Claims Data","volume":"57","author":"Wartmann","year":"2023","journal-title":"Neuroepidemiology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41584-023-00964-y","article-title":"High risk of autoimmune diseases after COVID-19","volume":"19","author":"Sharma","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","article-title":"COVID-19 and autoimmune diseases","volume":"33","author":"Liu","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"101783","DOI":"10.1016\/j.eclinm.2022.101783","article-title":"Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study","volume":"56","author":"Chang","year":"2023","journal-title":"eClinicalMedicine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1007\/s10067-023-06670-0","article-title":"Incident autoimmune diseases in association with SARS-CoV-2 infection: A matched cohort study","volume":"42","author":"Tesch","year":"2023","journal-title":"Clin. Rheumatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s10072-021-05785-z","article-title":"Immune-mediated neurological syndrome in SARS-CoV-2 infection: A review of literature on autoimmune encephalitis in COVID-19","volume":"43","author":"Payus","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1093\/brain\/awab302","article-title":"Acute and chronic neurological disorders in COVID-19: Potential mechanisms of disease","volume":"144","author":"Balcom","year":"2021","journal-title":"Brain"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3000605231191025","DOI":"10.1177\/03000605231191025","article-title":"Autoimmune myasthenia gravis and COVID-19. A case report-based review","volume":"51","author":"Croitoru","year":"2023","journal-title":"J. Int. Med. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s41983-022-00516-3","article-title":"The relationship between myasthenia gravis and COVID-19: A systematic review","volume":"58","author":"Tugasworo","year":"2022","journal-title":"Egypt. J. Neurol. Psychiatry Neurosurg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1007\/s00415-020-10263-1","article-title":"New onset of ocular myasthenia gravis in a patient with COVID-19: A novel case report and literature review","volume":"268","author":"Sriwastava","year":"2021","journal-title":"J. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.7326\/L20-0845","article-title":"Myasthenia Gravis Associated With SARS-CoV-2 Infection","volume":"173","author":"Restivo","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_39","unstructured":"(2023, September 15). Italian National Institute of Statistics Population Census. Available online: https:\/\/demo.istat.it\/."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: Executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"key":"ref_41","unstructured":"Waterhouse, J.A.H., Muir, C.S., Correa, P., and Powell, J. (1976). Cancer Incidence in Five Continents, IARC."},{"key":"ref_42","unstructured":"(2023, September 15). 2021. Available online: http:\/\/ec.europa.eu\/eurostat\/data\/database."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000110529","article-title":"Calculating Confidence Intervals for Rates and Ratios: Simplified Method Utilizing Tabular Values Based on the Poisson Distribution","volume":"2","author":"Schoenberg","year":"1983","journal-title":"Neuroepidemiology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1007\/s10792-023-02676-4","article-title":"Age of onset and factors affecting treatment responses in ocular myasthenia gravis","volume":"43","author":"Kemchoknatee","year":"2023","journal-title":"Int. Ophthalmol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archneur.56.1.25","article-title":"Late-onset myasthenia gravis: A changing scene","volume":"56","author":"Aarli","year":"1999","journal-title":"Arch. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archneur.1991.00530190081019","article-title":"Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey","volume":"48","author":"Somnier","year":"1991","journal-title":"Arch. Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3988\/jcn.2016.12.3.340","article-title":"Incidence and Prevalence of Myasthenia Gravis in Korea: A Population-Based Study Using the National Health Insurance Claims Database","volume":"12","author":"Park","year":"2016","journal-title":"J. Clin. Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/mus.24348","article-title":"Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa","volume":"51","author":"Mombaur","year":"2015","journal-title":"Muscle Nerve"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1468-1331.2012.03698.x","article-title":"A national epidemiological study of Myasthenia Gravis in Australia","volume":"19","author":"Gattellari","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000311012","article-title":"Nationwide population-based epidemiological study of myasthenia gravis in Taiwan","volume":"35","author":"Lai","year":"2010","journal-title":"Neuroepidemiology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"834212","DOI":"10.3389\/fneur.2022.834212","article-title":"The Epidemiology and Phenotypes of Ocular Manifestations in Childhood and Juvenile Myasthenia Gravis: A Review","volume":"13","author":"Heckmann","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ejpn.2017.07.011","article-title":"Juvenile myasthenia gravis","volume":"21","author":"Heckmann","year":"2017","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000328863","article-title":"Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years","volume":"36","author":"Pallaver","year":"2011","journal-title":"Neuroepidemiology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","year":"2014","journal-title":"J. Autoimmun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/103.3.579","article-title":"Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis","volume":"103","author":"Compston","year":"1980","journal-title":"Brain"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Van den Bulck, S., Cr\u00e8vecoeur, J., Aertgeerts, B., Delvaux, N., Neyens, T., Van Pottelbergh, G., Coursier, P., and Vaes, B. (2022). The impact of the Covid-19 pandemic on the incidence of diseases and the provision of primary care: A registry-based study. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0271049"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/S2352-4642(21)00066-3","article-title":"Children and young people remain at low risk of COVID-19 mortality","volume":"5","author":"Bhopal","year":"2021","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e817","DOI":"10.3399\/bjgp20X713021","article-title":"Impact of COVID-19 on loneliness, mental health, and health service utilisation: A prospective cohort study of older adults with multimorbidity in primary care","volume":"70","author":"Wong","year":"2020","journal-title":"Br. J. Gen. Pract."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/jamainternmed.2020.2492","article-title":"Caring for Older Adults With Diabetes During the COVID-19 Pandemic","volume":"180","author":"Sy","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"103409","DOI":"10.1016\/j.autrev.2023.103409","article-title":"Increased incidence of rheumatoid arthritis after COVID-19","volume":"22","author":"Sarmiento","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"102898","DOI":"10.1016\/j.jaut.2022.102898","article-title":"Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review","volume":"132","author":"Rojas","year":"2022","journal-title":"J. Autoimmun."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Mirmosayyeb, O., Moases Ghaffary, E., Mazdak, M., Bagheri, Z., Bagherieh, S., and Shaygannejad, V. (2022). Is Myasthenia Gravis a Real Complication of the COVID-19 Vaccine? A Case Report-Based Systematic Review. Can. J. Infect. Dis. Med. Microbiol., 2022.","DOI":"10.1155\/2022\/5009450"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1080\/01676830.2022.2062777","article-title":"Acute onset ocular myasthenia gravis after vaccination with the Oxford-AstraZeneca COVID-19 vaccine","volume":"42","author":"Maher","year":"2022","journal-title":"Orbit"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.3346\/jkms.2022.37.e50","article-title":"Early-Onset Myasthenia Gravis Following COVID-19 Vaccination","volume":"37","author":"Lee","year":"2022","journal-title":"J. Korean Med. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"21501327211051933","DOI":"10.1177\/21501327211051933","article-title":"A Case of COVID-19 Vaccine Associated New Diagnosis Myasthenia Gravis","volume":"12","author":"Chavez","year":"2021","journal-title":"J. Prim. Care Community Health"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"120225","DOI":"10.1016\/j.jns.2022.120225","article-title":"Flare of myasthenia gravis induced by COVID-19 vaccines","volume":"436","author":"Ishizuchi","year":"2022","journal-title":"J. Neurol. Sci."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/1\/236\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:45:03Z","timestamp":1760132703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/1\/236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,30]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["jcm13010236"],"URL":"https:\/\/doi.org\/10.3390\/jcm13010236","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,30]]}}}